[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US4885169A - Cosmetic composition containing glycoproteins for the skin care - Google Patents

Cosmetic composition containing glycoproteins for the skin care Download PDF

Info

Publication number
US4885169A
US4885169A US06/688,738 US68873885A US4885169A US 4885169 A US4885169 A US 4885169A US 68873885 A US68873885 A US 68873885A US 4885169 A US4885169 A US 4885169A
Authority
US
United States
Prior art keywords
glycoprotein
composition
cosmetic composition
skin
glycoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US06/688,738
Inventor
Giovanni Gazzani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crinos Industria Farmacobiologica SpA
Original Assignee
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmacobiologica SpA filed Critical Crinos Industria Farmacobiologica SpA
Assigned to CRINOS INDUSTRIA FARMACOBIOLOGICA SPA. reassignment CRINOS INDUSTRIA FARMACOBIOLOGICA SPA. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: GAZZANI, GIOVANNI
Application granted granted Critical
Publication of US4885169A publication Critical patent/US4885169A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to a cosmetic composition containing glycoproteins, particularly suitable for skin treatment.
  • glycoproteins are known as a class of compounds having highly different and heterogenous function in organisms.
  • glycoproteins which essentially form the mucus, is protecting the internal tissues (in the digesting and respiratory tracts) against mechanical, chemical and microbial damages.
  • the skin which under several aspect is like the mucose, is on the contrary efficaciously protected by an inert corneal layer against irritants.
  • FR-A-2300572 discloses a method for the extraction of soluble glycoproteins and/or of mucopolysaccharides and of accompanying substances from the natural sources (animal organs, vegetal tissues and microorganisms) in which they are present.
  • the resulting raw mixtures can be used in the pharmaceutical, cosmetic or food industry.
  • a mixture comprising both the subject extracted substances and a mixture of complex lipids, having trophic and protective effects for the skin.
  • FR-A-2036453 relates to a cosmetic product in which acidic mucopolysaccharides (also indicated as glycosaminoglucuronanes) are present in a percentage of 0.01 to 2% by weight, the cosmetic product being used as soap, shampoo, beauty cream and tooth paste.
  • acidic mucopolysaccharides also indicated as glycosaminoglucuronanes
  • GB-A-1166939 relates to the extraction of glycopeptides for which the use as a drug for the treatment of inflammatory diseases and particularly of ulcers is indicated.
  • glycoproteins of natural origin as obtained from the mucosa and from the internal epithelial tissues of mammalian beings, in combination with a hygroscopic agent, show with respect to the skin protecting, revitalizing and antiwrinkle activities.
  • glycoproteins of natural origin as obtained by extraction from gastric and intestinal mucosa of mammalians, and the mucines obtained from the mucus as produced by the aforesaid mucosa, show a surprising hydrating, elasticizing and wrinkle activity in the treatment of the senescen forms of the skin, particularly of the skin of the face and of the hands, which more frequently are subjected to physical and chemical attacks. More particularly in the case of the face wrinkles the application of the above indicated glycoproteins shows a favourable influence.
  • the skin already after the first treatment is more hydrated, more turgid, more elastic, and more vital and the wrinkles are attenuated and extended.
  • a simple water solution of the glycoproteins has no anti-wrinkle evident action as in the case in which they are carried by means of hygrostatic excipients, by which they are maintained on the skin for a longer time in solution.
  • a cosmetic composition for treaating the skin which contains, as the active ingredient, at least a glycoprotein of natural origin or their mixtures, obtained by extraction from gastric or intestinal mucosa of mammalians or from the mucus secreted therefrom, preferably as a water solution, in combination with an hygrostatic excipient.
  • glycoproteins useful for the cosmetic compositions according to the present invention of particular efficacy is that obtained by extraction from the gastric or duodenal mucosa of swine according to the process disclosed in United Kingdom Pat. No. 1,166,939.
  • This material can be extracted as described in the United Kingdom Pat. No. 1,166,939 from the gastric mucosa or duodenum of mammals or the mucus secreted therefrom by: (a) hydrolyzing these in water at a temperature of about 50° C. to 100° C.
  • non-solvents include acetone or a lower alkanol having one to four carbons.
  • This glycoprotein is an amorphous, ivory coloured, hygroscopic, water soluble and insoluble in the organic solvents powder, and as regards the composition it may be defined as follows:
  • the activity of the glycoproteins of the present invention is essentially shown only if in the composition is in a hygrostatic excipient which is capable of retaining for an extended time the active component, namely the glycoprotein, or better its water solution into contact with the skin.
  • hygrostatic sustances there are to be particularly mentioned glycerine, propylene glycol, sorbitol, generally polyalcohols and the normal hydrating agents such as: NMF (Natural Moisturing Factor), urea, aminoacids, pyrrolidon carboxylic acid, etc.
  • the normal dosages of use of the glycoproteins of the invention are of between 0.5% and 5% by weight of the composition and the glycoproteins may be combined with vitaminic nutrient factors and aminoacids, placenta extracts, vegetal derivatives etc.
  • a remarkable feature of the present invention is that only the above defined glycoproteins show the aforesaid activity.
  • glycoproteins of natural origin such as those of milk, do not show the above indicated effect.
  • the tests have been carried out on a total of 20 persons, divided in four groups each comprising five persons.
  • Groups number one has been treated with placebo, consisting of a 2.5 water solution of glycerine
  • group No. 2 has been treated with glycoprotein obtained according to the aforesaid U.K. Patent and previously defined, group No. 3 with glycoprotein obtained from milk and group No. 4 with mucine, (the three glycoproteins having been dissolved in glycerine at the concentration of 1%).
  • a good activity is also detected with the mucine whereas, the activity of the milk glycoprotein is practically absent.
  • compositions according to the invention are reported only for illustrating purposes, wherein by "glycoprotein" the substance as above defined and obtained with the process with U.K. Pat. No. 1,166,939 is meant.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A cosmetic composition is disclosed containing natural glycoproteins useful with advantageous effect for the skin care.

Description

FIELD OF THE INVENTION
The present invention relates to a cosmetic composition containing glycoproteins, particularly suitable for skin treatment.
The glycoproteins are known as a class of compounds having highly different and heterogenous function in organisms.
They are widely distributed in the cells of the vertebrates, of the invertebrates, of the plants and of the microorganisms.
In the case of the vertebrates, and particularly in human beings, one of the most important roles fulfilled by glycoproteins which essentially form the mucus, is protecting the internal tissues (in the digesting and respiratory tracts) against mechanical, chemical and microbial damages.
In turn the skin, which under several aspect is like the mucose, is on the contrary efficaciously protected by an inert corneal layer against irritants.
However such a natural protection of the skin is often insufficient mainly when these negative actions are intense and often repeated. In that case the skin appears dry, asphyxiated, starved and senescent, besides being tendentially wrinkled. The present studies on the activities of the natural glycoproteins were and are mainly aimed at the behaviour of the mucosa protected by the mucus in the presence of irritating agents (such as for instance cigarette smoke in the respiratory tract or irritating substances in the digesting tract), and particularly at the reaction of the epithelium to the irritating stimuli.
STATEMENT OF PRIOR DISCLOSURES
FR-A-2300572 discloses a method for the extraction of soluble glycoproteins and/or of mucopolysaccharides and of accompanying substances from the natural sources (animal organs, vegetal tissues and microorganisms) in which they are present. The resulting raw mixtures, either alone or in admixture, can be used in the pharmaceutical, cosmetic or food industry.
More particularly a mixture is disclosed comprising both the subject extracted substances and a mixture of complex lipids, having trophic and protective effects for the skin.
FR-A-2036453 relates to a cosmetic product in which acidic mucopolysaccharides (also indicated as glycosaminoglucuronanes) are present in a percentage of 0.01 to 2% by weight, the cosmetic product being used as soap, shampoo, beauty cream and tooth paste.
GB-A-1166939 relates to the extraction of glycopeptides for which the use as a drug for the treatment of inflammatory diseases and particularly of ulcers is indicated.
OBJECTS AND SUMMARY OF THE INVENTION
It has been now surprisingly found and is the basic principle of the present invention, that glycoproteins of natural origin, as obtained from the mucosa and from the internal epithelial tissues of mammalian beings, in combination with a hygroscopic agent, show with respect to the skin protecting, revitalizing and antiwrinkle activities.
More specifically it has been found that the glycoproteins of natural origin, as obtained by extraction from gastric and intestinal mucosa of mammalians, and the mucines obtained from the mucus as produced by the aforesaid mucosa, show a surprising hydrating, elasticizing and wrinkle activity in the treatment of the senescen forms of the skin, particularly of the skin of the face and of the hands, which more frequently are subjected to physical and chemical attacks. More particularly in the case of the face wrinkles the application of the above indicated glycoproteins shows a favourable influence.
The skin already after the first treatment, is more hydrated, more turgid, more elastic, and more vital and the wrinkles are attenuated and extended.
The beneficial results of the treatment are even more evident in the case of dry, asphyxiated, starved and senescent skin, which is more readily subjected to wrinkles.
It is to be pointed out that, in order for the glycoproteins to show their effect on the skin, it is necessary that the excipients be such that the glycoproteins remain on the skin in solution as much long as possible.
A simple water solution of the glycoproteins has no anti-wrinkle evident action as in the case in which they are carried by means of hygrostatic excipients, by which they are maintained on the skin for a longer time in solution.
Consequently it is the object of the present invention to provide a cosmetic composition for treaating the skin which contains, as the active ingredient, at least a glycoprotein of natural origin or their mixtures, obtained by extraction from gastric or intestinal mucosa of mammalians or from the mucus secreted therefrom, preferably as a water solution, in combination with an hygrostatic excipient.
Among the glycoproteins useful for the cosmetic compositions according to the present invention of particular efficacy is that obtained by extraction from the gastric or duodenal mucosa of swine according to the process disclosed in United Kingdom Pat. No. 1,166,939. This material can be extracted as described in the United Kingdom Pat. No. 1,166,939 from the gastric mucosa or duodenum of mammals or the mucus secreted therefrom by: (a) hydrolyzing these in water at a temperature of about 50° C. to 100° C. for from 10 to 45 minutes at a pH of 1 to 10; (b) removing the acidic products of the hydrolysis; and (c) diluting the product of the previous step (b) with a non-solvent for the resulting glycopeptide to precipitate the glycoprotein or mixture thereof. Preferred non-solvents include acetone or a lower alkanol having one to four carbons.
This glycoprotein, as obtained, is an amorphous, ivory coloured, hygroscopic, water soluble and insoluble in the organic solvents powder, and as regards the composition it may be defined as follows:
______________________________________                                    
                      Limits:                                             
______________________________________                                    
Total aminoacids:       18-28%                                            
Hexosamines:            27-43%                                            
Total hexoses:          25-30%                                            
Sialic acids:            4-5%                                             
Viscosity at 20° C. in 0.5 Na Cl                                   
                        1.8-2.3 cP                                        
______________________________________                                    
According to the above definition, the activity of the glycoproteins of the present invention is essentially shown only if in the composition is in a hygrostatic excipient which is capable of retaining for an extended time the active component, namely the glycoprotein, or better its water solution into contact with the skin. Among these hygrostatic sustances, there are to be particularly mentioned glycerine, propylene glycol, sorbitol, generally polyalcohols and the normal hydrating agents such as: NMF (Natural Moisturing Factor), urea, aminoacids, pyrrolidon carboxylic acid, etc.
The normal dosages of use of the glycoproteins of the invention are of between 0.5% and 5% by weight of the composition and the glycoproteins may be combined with vitaminic nutrient factors and aminoacids, placenta extracts, vegetal derivatives etc. A remarkable feature of the present invention is that only the above defined glycoproteins show the aforesaid activity.
In fact, other glycoproteins of natural origin, such as those of milk, do not show the above indicated effect.
This fact has been confirmed by comparative tests, as hereinafter reported, which, also confirm the properties of the glycoproteins according to the present invention.
The tests have been carried out on a total of 20 persons, divided in four groups each comprising five persons.
Groups number one has been treated with placebo, consisting of a 2.5 water solution of glycerine, group No. 2 has been treated with glycoprotein obtained according to the aforesaid U.K. Patent and previously defined, group No. 3 with glycoprotein obtained from milk and group No. 4 with mucine, (the three glycoproteins having been dissolved in glycerine at the concentration of 1%).
The daily treatments were carried out for 15 days consecutively and at the end the results were observed.
The resuming results are reported in the following table:
______________________________________                                    
        Hydrating    Elasticizing                                         
                               Anti-wrinkle                               
Group   activity     activity  activity                                   
______________________________________                                    
1       +            -                                                    
2       ++           +         +++                                        
3       +            +         +                                          
4       ++           +-        ++                                         
______________________________________                                    
As it is seen from the above table, in the case of group 2 treated with the preferred glycoprotein according to the invention, an optimum activity is observed for all 3 parameters.
A good activity is also detected with the mucine whereas, the activity of the milk glycoprotein is practically absent.
In the following example some cosmetic compositions according to the invention are reported only for illustrating purposes, wherein by "glycoprotein" the substance as above defined and obtained with the process with U.K. Pat. No. 1,166,939 is meant.
EXAMPLE 1
______________________________________                                    
Creams                                                                    
______________________________________                                    
Glycoprotein              2 g                                             
Glycerine                 10 g                                            
NMF                       2.5 g                                           
Polyoxyethylenesorbitan monostearate                                      
                          4 g                                             
Sorbitan monostearate     2.5 g                                           
Spermaceti                7 g                                             
Decyl oleate              8 g                                             
Preserving agent          enough                                          
Perfume                   enough                                          
Water to 100 g                                                            
______________________________________                                    
EXAMPLE 2
______________________________________                                    
Fluid emulsion                                                            
______________________________________                                    
Glycoprotein             2 g                                              
70% Sorbitol             13 g                                             
Urea                     1 g                                              
Stearo-isostearate of glycerol and                                        
                         3.5 g                                            
propyleneglycol                                                           
Oxyethylenated fatty alcohols                                             
                         2.5 g                                            
Cetylstearilic alcohol   9 g                                              
Octyldodecanol           enough                                           
Preserving agents        enough                                           
Perfume                  enough                                           
Water to 100 g                                                            
______________________________________                                    
EXAMPLE 3
______________________________________                                    
Gel                                                                       
______________________________________                                    
Glycoprotein             1.5 g                                            
Neutralized carboxyvinylpolymer                                           
                         1.2 g                                            
Propyleneglycol          8 g                                              
Preserving agents        enough                                           
Perfume                  enough                                           
Water to 100 g                                                            
______________________________________                                    
EXAMPLE 4
______________________________________                                    
Lotion                                                                    
______________________________________                                    
Glycoprotein       1 g                                                    
Glycerine          7 g                                                    
95% Alcohol       10 ml                                                   
Preserving agents enough                                                  
Perfume           enough                                                  
Water to 100 mg                                                           
______________________________________                                    

Claims (7)

I claim:
1. A cosmetic composition for hydrating the skin, comprising at least one naturally derived, purified glycoprotein substantially free of low molecular weight products and having been isolated from the gastric mucosa or duodenum of mammals by:
(a) hydrolyzing said mucosa or duodenum in water at a temperature of 50° C. to 100° C. for 10 minutes to 45 minutes at a pH of 1 to 10;
(b) removing acidic products of the hydrolysis; and
(c) diluting the product of step (b) with a non-solvent for the glycoprotein to precipitate said glycoprotein, said composition containing also water and at least one hygrostatic excipient, said composition being characterized by its ability to remain on the skin for an extended period of time.
2. The composition of claim 1, wherein said glycoprotein is extracted from mucus secreted by swines.
3. The composition of claim 1, containing a mixture of glycoproteins.
4. The cosmetic composition according to claim 1, containing at least one supplementary ingredient selected from the group consisting of vitaminic and aminoacids, placenta extracts and mixtures thereof.
5. The cosmetic composition according to claim 1, wherein said hygrostatic excipient is selected from the group consisting of glycerine, propylene glycol, sorbitol, polyalcohols, NMF (Natural Hydrating Factor), urea, aminoacids, pyrrolidone-carboxylic acid and mixtures thereof.
6. The cosmetic composition according to claim 1, wherein said glycoprotein is contained in dosage units varying from 0.5 to 5% by weight of the total composition.
7. The composition of claim 1, also containing cosmetically acceptable ingredients adapted to form a cream, an emulsion or a gel.
US06/688,738 1984-01-09 1985-01-04 Cosmetic composition containing glycoproteins for the skin care Expired - Fee Related US4885169A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19076A/84 1984-01-09
IT19076/84A IT1180156B (en) 1984-01-09 1984-01-09 GLYCOPROTEIN-BASED COSMETIC COMPOSITION FOR SKIN TREATMENT

Publications (1)

Publication Number Publication Date
US4885169A true US4885169A (en) 1989-12-05

Family

ID=11154336

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/688,738 Expired - Fee Related US4885169A (en) 1984-01-09 1985-01-04 Cosmetic composition containing glycoproteins for the skin care

Country Status (6)

Country Link
US (1) US4885169A (en)
EP (1) EP0149872B1 (en)
JP (1) JP2597084B2 (en)
AT (1) ATE43066T1 (en)
DE (1) DE3478198D1 (en)
IT (1) IT1180156B (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5351698A (en) * 1988-11-15 1994-10-04 Family Health International Bidirectionally donnable generally tubular sheath articles, and apparatus and method for making and using same
US5361779A (en) * 1992-11-18 1994-11-08 Family Health International Tubular sheathing article comprising knitted retention structure, and method of making the same
US5525336A (en) * 1993-02-19 1996-06-11 Green; Howard Cosmetic containing comeocyte proteins and transglutaminase, and method of application
US6267957B1 (en) 1998-01-20 2001-07-31 Howard Green Attaching agents to tissue with transglutaminase and a transglutaminase substrate
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
WO2003059221A1 (en) * 2002-01-11 2003-07-24 Purdue Research Foundation Composition and method for inhibiting hypersensitivity
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US11696888B2 (en) 2020-05-27 2023-07-11 Mary Kay Inc. Topical compositions and methods

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594690B1 (en) * 1986-02-21 1989-11-24 Thorel Jean Noel REGENERATING AND STIMULATING COMPOSITIONS OF THE DERMIS
FR2595247B1 (en) * 1986-03-06 1988-09-23 Sederma Sa USE IN COSMETOLOGY OF MUCUS EXTRACTS OR DIGESTIVE SUGAS OF GASTEROPODS AND PREPARATION OF SUCH EXTRACTS
US5443855B1 (en) * 1991-09-18 1998-02-10 Revlon Consumer Prod Corp Cosmetics and pharmaceuticals containing extensins and related methods
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1166939A (en) * 1966-09-29 1969-10-15 Prephar Prospection De Rech S Process For The Extraction Of A Glycopeptide
DE1813154A1 (en) * 1968-12-06 1970-07-02 Helmut Seuss Skin cream containing snail secretion
GB1210022A (en) * 1967-09-14 1970-10-28 Prephar Prospection De Rech S Cosmetic therapeutic preparations containing animal organ extracts
FR2036453A5 (en) * 1969-03-14 1970-12-24 Henry Michel Cosmetic preparations additive
US3607650A (en) * 1970-05-15 1971-09-21 Prephar Process for the enzymatic extraction and purification of a glycopeptide obtained from animal organs,useful as a drug
US4108849A (en) * 1974-02-25 1978-08-22 Andre Thomas Process for extracting and processing glycoproteins, mucopolysaccharides and accompanying substances
US4425329A (en) * 1979-09-07 1984-01-10 Kao Soap Co., Ltd. Water-in-oil type cosmetic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2261755A1 (en) * 1974-02-25 1975-09-19 Thomas Andre Glyco protein and mucopolysaccharides extraction - from naturally occuring materials fr use in cosmetics
FR2300572A2 (en) * 1975-02-11 1976-09-10 Thomas Andre Glyco protein and mucopolysaccharides extraction - from naturally occuring materials fr use in cosmetics
JPS57500562A (en) * 1980-04-25 1982-04-01
JPS5998727A (en) * 1982-11-26 1984-06-07 Shiseido Co Ltd Emulsified composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1166939A (en) * 1966-09-29 1969-10-15 Prephar Prospection De Rech S Process For The Extraction Of A Glycopeptide
GB1210022A (en) * 1967-09-14 1970-10-28 Prephar Prospection De Rech S Cosmetic therapeutic preparations containing animal organ extracts
DE1813154A1 (en) * 1968-12-06 1970-07-02 Helmut Seuss Skin cream containing snail secretion
FR2036453A5 (en) * 1969-03-14 1970-12-24 Henry Michel Cosmetic preparations additive
US3607650A (en) * 1970-05-15 1971-09-21 Prephar Process for the enzymatic extraction and purification of a glycopeptide obtained from animal organs,useful as a drug
US4108849A (en) * 1974-02-25 1978-08-22 Andre Thomas Process for extracting and processing glycoproteins, mucopolysaccharides and accompanying substances
US4425329A (en) * 1979-09-07 1984-01-10 Kao Soap Co., Ltd. Water-in-oil type cosmetic composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Horowitz et al., (Eds), The Glycoproteins, vol. 1, Academic Press, N.Y., 1977, pp. 16 17. *
Horowitz et al., (Eds), The Glycoproteins, vol. 1, Academic Press, N.Y., 1977, pp. 16-17.

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5351698A (en) * 1988-11-15 1994-10-04 Family Health International Bidirectionally donnable generally tubular sheath articles, and apparatus and method for making and using same
US5361779A (en) * 1992-11-18 1994-11-08 Family Health International Tubular sheathing article comprising knitted retention structure, and method of making the same
US5525336A (en) * 1993-02-19 1996-06-11 Green; Howard Cosmetic containing comeocyte proteins and transglutaminase, and method of application
US6511957B1 (en) 1993-02-19 2003-01-28 Howard Green Compositions containing corneocyte proteins
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US6267957B1 (en) 1998-01-20 2001-07-31 Howard Green Attaching agents to tissue with transglutaminase and a transglutaminase substrate
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US20060110379A1 (en) * 1998-01-20 2006-05-25 Pericor Science, Inc. Linkage of agents using microparticles
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7879823B2 (en) 1999-11-05 2011-02-01 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
WO2003059221A1 (en) * 2002-01-11 2003-07-24 Purdue Research Foundation Composition and method for inhibiting hypersensitivity
US11696888B2 (en) 2020-05-27 2023-07-11 Mary Kay Inc. Topical compositions and methods

Also Published As

Publication number Publication date
JP2597084B2 (en) 1997-04-02
DE3478198D1 (en) 1989-06-22
ATE43066T1 (en) 1989-06-15
EP0149872A3 (en) 1985-08-28
EP0149872B1 (en) 1989-05-17
IT1180156B (en) 1987-09-23
EP0149872A2 (en) 1985-07-31
JPS6110504A (en) 1986-01-18
IT8419076A0 (en) 1984-01-09

Similar Documents

Publication Publication Date Title
US4885169A (en) Cosmetic composition containing glycoproteins for the skin care
US5843911A (en) Hyaluronidase inhibitor containing god-type ellagitannin as active ingredient
DE69805100T2 (en) ANTIMICROBIALLY EFFECTIVE PHOSPHOLIPIDES WITH ANTIMICROBIAL SUBSTANCES
JPH09157176A (en) Antiallergic agent containing extract of hypericum erectum thunb. and tilia miqueliana maxim.
EP0109993B1 (en) Method for extracting propolis and water soluble dry propolis powder obtained thereby and cosmetic and pharmaceutical preparations containing same
KR20160108971A (en) Cosmetic compositions for the skin having pimplesthereon and manufacturing method thereof
KR102099269B1 (en) Two-part skin care formulations
JPH0987189A (en) Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne
JPH0873342A (en) Skin external preparation or bathing agent containing rubi fructus extract
JP3722511B2 (en) Skin preparations and bath preparations
US6159450A (en) Use of Ginkgo biloba flavonoidic extract substantially devoid of terpenes for oral hygiene and composition containing such extract
US20050176677A1 (en) Cosmetic composition comprising monosaccharides or polysaccharides, uses and treatment methods
JPH10158305A (en) Antimicrobial and antiseptic agent containing chitosan derivative
KR101383519B1 (en) Composition having excellent antibacterial effect and manufacturing method thereof and cosmetic composition comprising thereof
KR100340185B1 (en) Anti-wrinkle cosmetic composition containing PAECILOMYCES JAPONICA extract
KR100610951B1 (en) Composition for Skin-antiacne
JPH03112912A (en) Cosmetic composition
KR100562077B1 (en) Method for manufacturing Punica granatum L. extract having antibacterial property and antibacterial compositions for dermatologically external preparation containing Punica granatum L. extract manufactured by the above method
KR102488864B1 (en) Composition Containing Terminalia Chebula Extract and Artemisia Extract for Controlling Skin Bacterial Flora Growth, or Enhancing Skin Immunity
JP3001121B2 (en) External preparation for skin
JP3874477B2 (en) Melanin production promoter containing chitosan derivative
JPH0665041A (en) Skin external preparation
JPH107582A (en) Skin lotion
DE68906775T2 (en) Protect, nourish and treat the skin.
JP3516792B2 (en) External preparation for skin

Legal Events

Date Code Title Description
AS Assignment

Owner name: CRINOS INDUSTRIA FARMACOBIOLOGICA SPA., PIAZZA XX

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:GAZZANI, GIOVANNI;REEL/FRAME:004355/0370

Effective date: 19841210

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19971210

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362